Tuesday, September 20, 2022 11:59:50 PM
They decided to focus on vitamins today and not address anything else.
No one is talking because so many eyes are watching. Not just investor eyes.
SBFMs website today literally pivoted from covid and adva-27a to vitamins, which they are licensed to sell.
https://sunshinebiopharma.com/common-causes-for-essential-amino-acids-deficiency/
http://www.stocksequity.com/active-stocks/seducing-stocks-scisparc-ltd-nasdaqsprc-8-65-sunshine-biopharma-inc-nasdaqsbfm-2-70/
Seducing stocks: SciSparc Ltd. (NASDAQ:SPRC -8.65%), Sunshine Biopharma, Inc. (NASDAQ:SBFM -2.70%)
Sunshine Biopharma, Inc. (NASDAQ:SBFM)’s Analysis & Performances to Discover
Sunshine Biopharma, Inc., belongs to Healthcare sector and Drug Manufacturers – Specialty & Generic industry. The company’s total Outstanding Shares of 18.89M. SBFM flaunted -2.70% to reach at $0.86 during previous trading session. The company has experienced volume of 109,240 shares while on average the company has a capacity of trading 1.09M share.
Observing the Technical Indicators:
Sunshine Biopharma, Inc. institutional ownership is held at 4.00% while insider ownership was 0.80%. As of now, SBFM has a P/S, P/E and P/B values of 41.89, 0 and 0.33 respectively. Its P/Cash is valued at 0.40.
The Company’s net profit margin for the 12 months at 0. Comparatively, the gazes have a Gross margin 47.30%.
Profitability ratios:
Looking into the profitability ratios of SBFM stock, an investor will find its ROE, ROA, ROI standing at -38.10%, -34.30% and -605.80%, respectively.
Reading RSI Indicator
Sunshine Biopharma, Inc. (SBFM) attained alert from day Traders as RSI reading reached at 24.18. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. Traditionally, and according to Wilder, RSI is considered overbought when above 70 and oversold when below 30. Signals can also be generated by looking for divergences, failure swings, and centerline crossovers. RSI can also be used to identify the general trend. These traditional levels can also be adjusted to better fit the security or analytical requirements. Raising overbought to 80 or lowering oversold to 20 will reduce the number of overbought/oversold readings. Short-term traders sometimes use 2-period RSI to look for overbought readings above 80 and oversold readings below 20.
Earnings per Share Details of Sunshine Biopharma, Inc.:
The EPS of SBFM is strolling at -1.60, measuring its EPS growth this year at -74.50%. As a result, the company has an EPS growth of 0 for the approaching year.
Given the importance of identifying companies that will ensure earnings per share at a tall rate, we later obsession to umpire how to identify which companies will achieve high amassing rates. One obvious showing off to identify high earnings per portion count together companies are to locate companies that have demonstrated such build up beyond the p.s. 5 to 10 years.
What Does the Payout Ratio Tell You?
The payout ratio is a key financial metric used to determine the sustainability of a company’s dividend payments. It is the amount of dividends paid to shareholders relative to the total net income of a company.
Formula for the Payout Ratio Is
“Payout Ratio = Dividends / Earnings”
Is It Overvalued? Look at the Payout Ratio of SPRC, SBFM
The payout ratio shows the proportion of earnings paid out as dividends to shareholders, typically expressed as a percentage of the company’s earnings.
The payout ratio can also be expressed as dividends paid out as a proportion of cash flow.
The payout ratio is also known as the dividend payout ratio.
SPRC has a Payout Ratio of 0 and SBFM has a Payout Ratio of 0.
Recent SBFM News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:05:31 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 03/05/2024 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:05:35 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/23/2024 09:03:01 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/21/2024 09:28:39 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 02/21/2024 01:24:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 10:01:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 04:39:32 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:53:03 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 02/14/2024 04:18:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/13/2024 05:15:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/12/2024 09:05:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 02:04:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:17:56 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 02/01/2024 09:17:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 05:38:24 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/08/2024 01:10:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:59:51 PM
- Sunshine Biopharma Moves Principal Office to New York City • GlobeNewswire Inc. • 12/04/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 02:00:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 04:18:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/20/2023 05:06:33 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/19/2023 04:10:36 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM